Sandra Dovero
Ingénieur/technicien
/ CNRS/ Équipe
None
/ Contact
+33 5 33 51 47 19
www.orcid.org/0000-0002-5781-1328
/ Adresse
IMN - UMR 5293 - CNRS/Université de Bordeaux - Centre Broca Nouvelle-Aquitaine – 3e étage - 146 rue Léo-Saignat- CS 61292 – Case 28 - 33076 Bordeaux cedex - France
Publications
-
Nigral ATP13A2 depletion induces Parkinson’s disease-related neurodegeneration in a pilot study in non-human primates
npj Parkinsons Dis.. 2024-08-01. 10(1)
10.1038/s41531-024-00757-4 -
Reconsidering α-Synuclein inclusion pathology in neurons, mice, and humans with an antibody sensing NAC engagement during α-Synuclein amyloid conversion
Preprint - Research Square. 2024-02-07.
10.21203/rs.3.rs-3921168/v1 -
Cortical Lewy body injections induce long-distance pathogenic alterations in the non-human primate brain
npj Parkinsons Dis.. 2023-09-19. 9(1)
10.1038/s41531-023-00579-w -
Functional and neuropathological changes induced by injection of distinct alpha-synuclein strains: A pilot study in non-human primates
Neurobiology of Disease. 2023-03-01. : 106086.
10.1016/j.nbd.2023.106086 -
Brain injections of glial cytoplasmic inclusions induce a multiple system atrophy-like pathology
Brain. 2022-03-14. 145(3) : 1001-1017.
10.1093/brain/awab374 -
In vivo susceptibility to energy failure parkinsonism and LRRK2 kinase activity
Neurobiology of Disease. 2022-01-01. 162 : 105579.
10.1016/j.nbd.2021.105579 -
Pilot Study Assessing the Impact of Intrathecal Administration of Variants AAV-PHP.B and AAV-PHP.eB on Brain Transduction in Adult Rhesus Macaques
Front. Bioeng. Biotechnol.. 2021-11-15. 9
10.3389/fbioe.2021.762209 -
Comparison of the expression and toxicity of AAV2/9 carrying the human A53T α-synuclein gene in presence or absence of WPRE
Heliyon. 2021-02-01. 7(2) : e06302.
10.1016/j.heliyon.2021.e06302 -
Evaluation of blood flow as a route for propagation in experimental synucleinopathy
Neurobiology of Disease. 2021-01-01. : 105255.
10.1016/j.nbd.2021.105255 -
Acute Striato-Cortical Synchronization Induces Focal Motor Seizures in Primates
Cerebral Cortex. 2020-08-08.
10.1093/cercor/bhaa212 -
Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primates
Brain. 2020-05-01. 143(5) : 1462-1475.
10.1093/brain/awaa096 -
Identification of distinct pathological signatures induced by patient-derived α-synuclein structures in nonhuman primates
Sci. Adv.. 2020-05-01. 6(20) : eaaz9165.
10.1126/sciadv.aaz9165 -
Identification of distinct pathological signatures induced by patient-derived α-synuclein structures in non-human primates
. 2019-10-31.
10.1101/825216 -
Transcription factor EB overexpression prevents neurodegeneration in experimental synucleinopathies
JCI Insight. 2019-08-22. 4(16)
10.1172/jci.insight.129719 -
Early prenatal exposure to MPTP does not affect nigrostrial neurons in macaque monkey.
Synapse. 2015-12-04. 70(2) : 52-56.
10.1002/syn.21876 -
Unexpected toxicity of very low dose MPTP in mice: A clue to the etiology of Parkinson’s disease?
Synapse. 2015-12-01. 70(2) : 49-51.
10.1002/syn.21875 -
Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys.
Ann Neurol.. 2014-02-18. 75(3) : 351-362.
10.1002/ana.24066 -
Immediate-early gene expression in structures outside the basal ganglia is associated to l-DOPA-induced dyskinesia.
Neurobiology of Disease. 2014-02-01. 62 : 179-192.
10.1016/j.nbd.2013.09.020 -
Coordinated reset has sustained aftereffects in Parkinsonian monkeys.
Ann Neurol.. 2012-11-01. 72(5) : 816-820.
10.1002/ana.23663 -
PSD-95 expression controls L-DOPA dyskinesia through dopamine D1 receptor trafficking
J. Clin. Invest.. 2012-10-08. 122(11) : 3977-3989.
10.1172/JCI59426 -
The associative and limbic thalamus in the pathophysiology of obsessive-compulsive disorder: An experimental study in the monkey
Transl Psychiatry. 2012-09-01. 2(9) : e161-e161.
10.1038/tp.2012.88 -
Systemic scAAV9 variant mediates brain transduction in newborn rhesus macaques.
Sci Rep. 2012-02-09. 2(1)
10.1038/srep00253 -
The translational value of the MPTP non-human primate model of Parkinsonism for deep brain stimulation research
2011 Annual International Conference of the IEEE Engineering in Medicine and Biology Society. 2011-08-01.
10.1109/IEMBS.2011.6090148 -
Inhibition of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) signaling in the striatum reverts motor symptoms associated with L-dopa-induced dyskinesia.
Proceedings of the National Academy of Sciences. 2010-11-29. 107(50) : 21824-21829.
10.1073/pnas.1012071107 -
Dopamine transporter binding is unaffected by L-DOPA administration in normal and MPTP-treated monkeys.
PLoS ONE. 2010-11-22. 5(11) : e14053.
10.1371/journal.pone.0014053 -
Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia.
Ann Neurol.. 2010-09-29. 68(5) : 619-628.
10.1002/ana.22097 -
Distinct changes in cAMP and extracellular signal-regulated protein kinase signalling in L-DOPA-induced dyskinesia.
PLoS ONE. 2010-08-23. 5(8) : e12322.
10.1371/journal.pone.0012322 -
Lentiviral overexpression of GRK6 alleviates L-dopa-induced dyskinesia in experimental Parkinson’s disease.
Science Translational Medicine. 2010-04-21. 2(28) : 28ra28-28ra28.
10.1126/scitranslmed.3000664 -
Lentiviral overexpression of GRK6 alleviates L-Dopa-induced dyskinesia in experimental parkinson’s disease
Science Translational Medicine. 2010-04-21. 2(28) : 28ra28-28ra28.
10.1126/scitranslmed.3000664 -
IGF-1 signaling reduces neuro-inflammatory response and sensitivity of neurons to MPTP.
Neurobiology of Aging. 2009-12-01. 30(12) : 2021-2030.
10.1016/j.neurobiolaging.2008.02.009 -
Enhanced preproenkephalin-B-derived opioid transmission in striatum and subthalamic nucleus converges upon globus pallidus internalis in L-3,4-dihydroxyphenylalanine-induced dyskinesia.
Biological Psychiatry. 2007-04-01. 61(7) : 836-844.
10.1016/j.biopsych.2006.06.038 -
Levodopa-induced dyskinesia in MPTP-treated macaques is not dependent on the extent and pattern of nigrostrial lesioning.
European Journal of Neuroscience. 2005-07-01. 22(1) : 283-287.
10.1111/j.1460-9568.2005.04196.x -
Involvement of sensorimotor, limbic, and associative basal ganglia domains in L-3,4-dihydroxyphenylalanine-induced dyskinesia
Journal of Neuroscience. 2005-02-23. 25(8) : 2102-2107.
10.1523/JNEUROSCI.5059-04.2005 -
Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia.
Ann Neurol.. 2004-10-27. 57(1) : 17-26.
10.1002/ana.20296 -
Asymmetrically lesioned mesencephalon in healthy rodents: call for caution.
Brain Research. 2004-10-01. 1022(1-2) : 251-253.
10.1016/j.brainres.2004.07.014 -
Compensatory regulation of striatal neuropeptide gene expression occurs before changes in metabolic activity of basal ganglia nuclei
Neurobiology of Disease. 2003-06-01. 13(1) : 46-54.
10.1016/S0969-9961(03)00011-1 -
Pattern of levodopa-induced striatal changes is different in normal and MPTP-lesioned mice.
Journal of Neurochemistry. 2003-03-01. 84(6) : 1246-1255.
10.1046/j.1471-4159.2003.01600.x -
Pattern of levodopa-induced striatal changes is different in normal and MPTP-lesioned mice.
Journal of Neurochemistry. 2003-03-01. 84(6) : 1246-1255.
10.1046/j.1471-4159.2003.01600.x -
Spontaneous long-term compensatory dopaminergic sprouting in MPTP-treated mice
Synapse. 2000-01-01. 38(3) : 363-368.
10.1002/1098-2396(20001201)38:3<363::AID-SYN16>3.0.CO;2-A -
Absence of MPTP-induced neuronal death in mice lacking the dopamine transporter.
Experimental Neurology. 1999-02-01. 155(2) : 268-273.
10.1006/exnr.1998.6995 -
Towards a dynamic approach of experimental parkinsonism
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 1998-11-01. 22(8) : 1317-1329.
10.1016/S0278-5846(98)00072-4 -
Kinetics of nigral degeneration in a chronic model of MPTP-treated mice
Neuroscience Letters. 1997-09-01. 234(1) : 47-50.
10.1016/S0304-3940(97)00663-0